PlainRecalls
FDA Drug Moderate Class II Terminated

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162-03), 25 x 2 mL Single Dose Vials per tray (NDC 63323-162-02); For IM use only, Not for IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reported: June 17, 2020 Initiated: April 20, 2020 #D-1297-2020

Product Description

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162-03), 25 x 2 mL Single Dose Vials per tray (NDC 63323-162-02); For IM use only, Not for IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reason for Recall

Presence of Particulate Matter - found in reserve sample vials at the firm.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
3,497,575 vials
Distribution
USA Nationwide and Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162-03), 25 x 2 mL Single Dose Vials per tray (NDC 63323-162-02); For IM use only, Not for IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.. Recalled by Fresenius Kabi USA, LLC. Units affected: 3,497,575 vials.
Why was this product recalled?
Presence of Particulate Matter - found in reserve sample vials at the firm.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 17, 2020. Severity: Moderate. Recall number: D-1297-2020.